# Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.

> **NCT03155451** · — · COMPLETED · sponsor: **RenJi Hospital** · enrollment: 43 (actual)

## Conditions studied

- Epithelial Ovarian Cancer

## Interventions

- **DIAGNOSTIC_TEST:** methylation markers screening

## Key facts

- **NCT ID:** NCT03155451
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-14
- **Primary completion:** 2017-10-18
- **Final completion:** 2017-10-18
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2017-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03155451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03155451, "Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03155451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*